Logo image of CII

BLACKROCK ENHAN LRG CAP CORE (CII) Stock Overview

NYSE:CII - US09256A1097

22.03 USD
+0.26 (+1.19%)
Last: 8/22/2025, 2:38:28 PM
Fundamental Rating

2

CII gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. CII may be in some trouble as it scores bad on both profitability and health. CII does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CII was profitable.
CII had a positive operating cash flow in the past year.
CII Yearly Net Income VS EBIT VS OCF VS FCFCII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 50M 100M 150M

1.2 Ratios

Industry RankSector Rank
ROA 13.69%
ROE 13.89%
ROIC 0.16%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CII Yearly ROA, ROE, ROICCII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 5 10 15

1.3 Margins

Industry RankSector Rank
OM 18%
PM (TTM) 1250%
GM 20.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CII Yearly Profit, Operating, Gross MarginsCII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 500 1K 1.5K

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, CII has less shares outstanding
The debt/assets ratio for CII is higher compared to a year ago.
CII Yearly Shares OutstandingCII Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M
CII Yearly Total Debt VS Total AssetsCII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M 800M

2.2 Solvency

CII has an Altman-Z score of 41.70. This indicates that CII is financially healthy and has little risk of bankruptcy at the moment.
CII has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
CII has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Although CII does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 41.7
ROIC/WACCN/A
WACCN/A
CII Yearly LT Debt VS Equity VS FCFCII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 200M 400M 600M 800M

2.3 Liquidity

CII has a Current Ratio of 0.02. This is a bad value and indicates that CII is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that CII may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
CII Yearly Current Assets VS Current LiabilitesCII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

CII shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.91%.
The Revenue has decreased by 0.00% in the past year.
EPS 1Y (TTM)-13.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.15%
Revenue 1Y (TTM)0%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CII Yearly Revenue VS EstimatesCII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.42, the valuation of CII can be described as very cheap.
CII's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.76.
Industry RankSector Rank
PE 7.42
Fwd PE N/A
CII Price Earnings VS Forward Price EarningsCII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.11
EV/EBITDA N/A
CII Per share dataCII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

CII has a Yearly Dividend Yield of 7.11%, which is a nice return.
CII's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 7.11%

5.2 History

CII has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
CII Yearly Dividends per shareCII Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

43.20% of the earnings are spent on dividend by CII. This is a bit on the high side, but may be sustainable.
DP43.2%
EPS Next 2YN/A
EPS Next 3YN/A
CII Yearly Income VS Free CF VS DividendCII Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2023 2024 50M 100M 150M
CII Dividend Payout.CII Dividend Payout, showing the Payout Ratio.CII Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK ENHAN LRG CAP CORE

NYSE:CII (8/22/2025, 2:38:28 PM)

22.03

+0.26 (+1.19%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners25.88%
Inst Owner Change-5.41%
Ins Owners0.01%
Ins Owner Change0%
Market Cap901.47M
Analysts0
Price TargetN/A
Short Float %0.28%
Short Ratio1.56
Dividend
Industry RankSector Rank
Dividend Yield 7.11%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP43.2%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date08-15 2025-08-15 (0.141)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.42
Fwd PE N/A
P/S 90.15
P/FCF 9.11
P/OCF 9.11
P/B 1
P/tB 1
EV/EBITDA N/A
EPS(TTM)2.97
EY13.48%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.42
FCFY10.98%
OCF(TTM)2.42
OCFY10.98%
SpS0.24
BVpS21.99
TBVpS21.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.69%
ROE 13.89%
ROCE 0.2%
ROIC 0.16%
ROICexc 0.16%
ROICexgc 0.16%
OM 18%
PM (TTM) 1250%
GM 20.8%
FCFM 990%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 79.2%
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 41.7
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80%
OCF growth 3YN/A
OCF growth 5YN/A